If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Directorate Changes

1 Apr 2019 10:16

RNS Number : 6613U
Cenkos Securities PLC
01 April 2019
 

 

1 April 2019

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Cenkos Securities plc

("Cenkos" or the "Company")

Directorate Changes

 

Cenkos Securities plc today confirms that as previously announced on 12 December 2018 Philip Anderson, Chief Financial Officer, stepped down from the Board on 31 March 2019. However, Philip will remain with the Company and will continue undertaking the controlled functions of Compliance Officer and Money Laundering Reporting Officer until his successor is in place.

 

The Board would like to thank Philip for his commitment and contribution to the Company and to the Board.

 

Enquiries:

 

Cenkos Securities plc

Anthony Hotson, Chief Executive

 

Tel: 0207 397 8900

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser

 

Tel: 0203 368 3552

Whitman Howard Limited

Nick Lovering, Broker

 

Tel: 0207 659 1224

Buchanan Communications

David Rydell, PR Adviser

 

Tel: 0207 466 5066

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAMMGGDLMDGLZG
Date   Source Headline
19th Feb 201810:00 amRNSForm 8.5 (EPT/NON-RI)
15th Feb 201811:26 amRNSEBT Share Purchase
15th Feb 20189:41 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20189:32 amRNSForm 8.5 (EPT/NON-RI)
6th Feb 20185:46 pmRNSHolding(s) in Company
6th Feb 201810:36 amRNSForm 8.5 (EPT/NON-RI)
5th Feb 20189:18 amRNSHolding(s) in Company
31st Jan 20189:37 amRNSFurther re Directorate Change
29th Jan 201810:49 amRNSHolding(s) in Company
29th Jan 201810:48 amRNSHolding(s) in Company
29th Jan 20189:37 amRNSForm 8.5 (EPT/NON-RI)
26th Jan 20181:59 pmRNSDirector/PDMR Shareholding
26th Jan 20187:00 amRNSEBT Share Purchase
25th Jan 20183:35 pmRNSTransaction in Own Shares
24th Jan 201810:31 amRNSForm 8.5 (EPT/NON-RI)
23rd Jan 201810:35 amRNSForm 8.5 (EPT/NON-RI)
22nd Jan 20189:35 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20189:58 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 201810:00 amRNSForm 8.5 (EPT/NON-RI)
17th Jan 20189:28 amRNSForm 8.5 (EPT/NON-RI)
16th Jan 20189:50 amRNSForm 8.5 (EPT/NON-RI)
15th Jan 20189:34 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 201811:11 amRNSForm 8.5 (EPT/NON-RI)
11th Jan 20189:18 amRNSForm 8.5 (EPT/NON-RI)
10th Jan 20189:23 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20189:44 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20189:44 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 20189:49 amRNSForm 8.5 (EPT/NON-RI)
5th Jan 201810:18 amRNSForm 8.5 (EPT/NON-RI)
4th Jan 201810:55 amRNSForm 8.5 (EPT/NON-RI)
3rd Jan 20189:58 amRNSForm 8.5 (EPT/NON-RI)
28th Dec 201710:59 amRNSForm 8.5 (EPT/NON-RI)
27th Dec 201710:55 amRNSForm 8.5 (EPT/NON-RI)
15th Dec 20179:58 amRNSForm 8.5 (EPT/NON-RI)
14th Dec 201710:16 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 201710:13 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 20172:58 pmRNSEBT Share Purchase
8th Dec 20172:30 pmRNSDirector/PDMR Shareholding
8th Dec 201711:48 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 201711:38 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20171:20 pmRNSHolding(s) in Company
24th Nov 20177:00 amRNSDirector/PDMR Shareholding
22nd Nov 20177:00 amRNSDirector/PDMR Shareholding
16th Nov 20179:36 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20171:06 pmRNSDirector/PDMR Shareholding
15th Nov 20179:25 amRNSForm 8.5 (EPT/NON-RI)
13th Nov 20174:03 pmRNSFurther re Directorate Change
9th Nov 201710:44 amRNSForm 8.5 (EPT/NON-RI)
7th Nov 20175:08 pmRNSHolding(s) in Company
7th Nov 201710:25 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.